Strategic Overview
Molbio Diagnostics is a pioneer in point-of-care molecular diagnostics. Headquartered in Goa, India, the company developed Truenat, a portable, battery-operated, IoT-enabled real-time PCR platform recognized globally for TB detection and drug susceptibility testing.
Innovation Portfolio
Truenat MTB Ultima
Portable real-time PCR platform for MTBC detection from sputum or oral swabs. Designed for point-of-care use with battery operation and minimal infrastructure requirements.
Molecular
Swab/Sputum
Truenat MTB-INH
Add-on molecular test for isoniazid resistance detection compatible with Truenat platform. Designed for point-of-care drug resistance screening in primary care settings.
Molecular
Sputum
Key Milestones
WHO endorsed Truenat as first point-of-care rapid molecular diagnostic platform for TB diagnosis (2020)
Deployed in 85+ countries across 8,293+ NAAT systems in India
Received Kochon Prize from Stop TB Partnership (2025)
Raised $85 million from Temasek for global expansion
Provides diagnostics for 30+ diseases including TB, COVID-19, HIV, dengue, malaria